Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FH5FA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $87,938
Award facts
- Contract value 100% obligated
- $87,937.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $87,937.84 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 mL vials. This firm fixed-price delivery order, issued on September 17, 2025, is expected to be completed by October 8, 2025, and represents a tactical fulfillment under the company's larger pharmaceutical supply agreement with the agency. The award carries no set-aside designation, allowing the vendor to compete on its merits within the open federal procurement market.
DMS Pharmaceutical Group holds a substantial single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026 under the SPE2DB program, which serves as the vehicle enabling this and similar delivery orders for pharmaceutical products supporting Department of Defense healthcare facilities worldwide. The company has established itself as a critical supplier within the federal pharmaceutical supply chain, specializing in the distribution of branded and generic prescription drugs, biologics, and medical consumables to military health facilities. This particular delivery order for Keytruda, an oncology treatment, exemplifies the breadth of specialized pharmaceutical products the vendor routinely procures for the Defense Logistics Agency's medical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FH5FA?
SPE2DB25FH5FA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FH5FA worth?
The government has obligated $87,938 on SPE2DB25FH5FA.
Is contract SPE2DB25FH5FA an order under another contract?
Yes. SPE2DB25FH5FA is a delivery order under SPE2DB22D9207, an indefinite delivery contract.
Was contract SPE2DB25FH5FA competed?
The extent of competition for SPE2DB25FH5FA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award